Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti-PD-1 Therapy in Locoregionally Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter, Randomized Controlled Clinical Trial

NCT07751289 is registered in ClinicalTrials.gov with Yanjie Zhang, MD as lead sponsor.

NCT NCT07751289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07751289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti-PD-1 Therapy in Locoregionally Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma: A Multicenter, Randomized Controlled Clinical Trial
Lead sponsor
Yanjie Zhang, MD
Phase
Phase 2
Overall status
Not yet recruiting
Start date
August 1, 2026
Completion date
December 31, 2032
Enrollment
217 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent head and neck squamous cell carcinoma